期刊文献+

抗炎药物在精神分裂症治疗中的研究进展 被引量:9

下载PDF
导出
摘要 综述抗炎药物在精神分裂症治疗中的应用。
出处 《临床精神医学杂志》 2014年第5期347-349,共3页 Journal of Clinical Psychiatry
基金 国家自然科学基金(81071093) 卫生行业基金研究项目(201002003)
  • 相关文献

参考文献26

  • 1Kirkpatrick B, Miller BJ. Inflammation and schizophrenia [J] . Schizophr Bull ,2013 ,39: 1174-1 179.
  • 2Miller BJ , Culpepper N, Rapaport MH, et al. Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies [J]. Prog Neuropsychopharmacol Bioi Psychiatry ,2013 ,42 :92-100.
  • 3Muller N, Dursun SM. Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now? [J]. J Psychopharmacol ,201 1,25 :713-714.
  • 4Zhang XY ,Zhou DF ,Cao LY ,et al. Changes in serum interleukin- 2 , -6 , and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia [J]. J Clin Psychiatry,2004 ,65 : 940-947.
  • 5OBrien SM, Scully P, Dinan TG. Increased tumor necrosis factor-alpha concentrations with interleukin4 concentrations in exacerbations of schizophrenia [J]. Psychiatry Res ,2008,160 :256-262.
  • 6Freudenreich 0, Brockman MA, Henderson DC, et al. Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR) [J]. Psychiatry Res,2010,176:99-102.
  • 7Benros ME, Mortensen PB, Eaton WW. Autoimmune diseases and infections as risk factors for schizophrenia [J] . Ann N Y Acad Sci, 2012,1262 :56-66.
  • 8Pae CV , Y oon CH, Kim TS, et a1. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines[J]. Int Immunopharmacol,2006, 6 :666-671.
  • 9Steiner J , Jacobs R, Panteli B, et al. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity [J] . Eur Arch Psychiatry Clin Neurosci ,2010 ,260 :509-518.
  • 10Muller N , Krause D, Dehning S, et al. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, doubleblind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment[J]. Schizophr Res,2010,121 :118-124.

同被引文献140

  • 1苏允爱,司天梅.神经递质谷氨酸及其抗精神病药物研究进展[J].中国临床药理学杂志,2004,20(3):224-227. 被引量:10
  • 2秦峰,郑洪波,马崔.精神分裂症与2型糖尿病相关问题的研究进展[J].国际精神病学杂志,2005,32(4):206-209. 被引量:14
  • 3钟伟英,张程赪.精神分裂症患者伴发糖尿病危险因素临床研究[J].临床心身疾病杂志,2007,13(4):325-326. 被引量:12
  • 4刘亮,贾福军,李恒芬,方春霞.精神分裂症患者致炎性细胞因子和酪氨酸羟化酶mRNA表达水平的研究[J].中华精神科杂志,2007,40(4):209-212. 被引量:2
  • 5Shenton ME, Dickey CC, Frumin M, et al. A review of MRI findings in schizophrenia[J]. Schizophr Res, 2001, 49 (1-2): 1-52.
  • 6Anath H, Popescu I, Critchley HD, et al. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry [ J]. Am J Psychiatry, 2002, 159 (9) : 1497-1505.
  • 7Haijma SV, Van Haren N, Cahn W, et al. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects [J]. Schizophr Bull, 2013, 39 (5) : 1129-1138.
  • 8Blakemore SJ. Imaging brain development: the adolescent brain[J]. Neuroimage, 2012, 61 (2) : 397-406.
  • 9Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia[J]. Schizophr Bull, 2008, 34 (2) : 354-366.
  • 10Cahn W, van Haren NE, Hulshoff Pol HE, et al. Brain volume changes in the first year of illness and 5-year outcome of schizophrenia [J]. Br J Psychiatry, 2006, 189 (7) : 381-382.

引证文献9

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部